Osteoporosis, Postmenopausal
"Osteoporosis, Postmenopausal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Descriptor ID |
D015663
|
| MeSH Number(s) |
C05.116.198.579.610 C18.452.104.579.610
|
| Concept/Terms |
Osteoporosis, Postmenopausal- Osteoporosis, Postmenopausal
- Perimenopausal Bone Loss
- Bone Loss, Postmenopausal
- Bone Losses, Postmenopausal
- Postmenopausal Bone Losses
- Osteoporosis, Post-Menopausal
- Osteoporoses, Post-Menopausal
- Osteoporosis, Post Menopausal
- Post-Menopausal Osteoporoses
- Post-Menopausal Osteoporosis
- Postmenopausal Osteoporosis
- Osteoporoses, Postmenopausal
- Postmenopausal Osteoporoses
- Bone Loss, Perimenopausal
- Bone Losses, Perimenopausal
- Perimenopausal Bone Losses
- Postmenopausal Bone Loss
|
Below are MeSH descriptors whose meaning is more general than "Osteoporosis, Postmenopausal".
Below are MeSH descriptors whose meaning is more specific than "Osteoporosis, Postmenopausal".
This graph shows the total number of publications written about "Osteoporosis, Postmenopausal" by people in this website by year, and whether "Osteoporosis, Postmenopausal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 2 | 3 |
| 2001 | 3 | 1 | 4 |
| 2002 | 0 | 3 | 3 |
| 2003 | 4 | 2 | 6 |
| 2004 | 2 | 1 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 4 | 2 | 6 |
| 2008 | 3 | 0 | 3 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 2 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Osteoporosis, Postmenopausal" by people in Profiles.
-
Nadeem S, Pervez A, Abid MA, Khalid RN, Rizvi NA, Aamdani SS, Ayub B, Mustafa MA, Ahmed S, Riaz M, Irfan K, Noordin S, Jafri L, Majid H, Umer M, Zehra N, Sheikh A, Haider AH, Khan AH. GRADE-ADOLOPMENT of clinical practice guideline for postmenopausal osteoporosis management-a Pakistani context. Arch Osteoporos. 2023 05 19; 18(1):71.
-
Black DM, Geiger EJ, Eastell R, Vittinghoff E, Li BH, Ryan DS, Dell RM, Adams AL. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. N Engl J Med. 2020 08 20; 383(8):743-753.
-
Qaseem A, Forciea MA, McLean RM, Denberg TD. Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians. Ann Intern Med. 2017 Jun 06; 166(11):818-839.
-
Watts NB, Cauley JA, Jackson RD, LaCroix AZ, Lewis CE, Manson JE, Neuner JM, Phillips LS, Stefanick ML, Wactawski-Wende J, Crandall C. No Increase in Fractures After Stopping Hormone Therapy: Results From the Women's Health Initiative. J Clin Endocrinol Metab. 2017 Jan 01; 102(1):302-308.
-
Gallagher JC, Palacios S, Ryan KA, Yu CR, Pan K, Kendler DL, Mirkin S, Komm BS. Effect of conjugated estrogens/bazedoxifene on postmenopausal bone loss: pooled analysis of two randomized trials. Menopause. 2016 10; 23(10):1083-91.
-
Hadji P, Ryan KA, Yu CR, Mirkin S, Komm BS. CE/BZA effects on bone and quality of life in European postmenopausal women: a pooled analysis. Climacteric. 2016 Oct; 19(5):482-7.
-
Bertonazzi A, Nelson B, Salvador J, Umland E. The smallest available estradiol transdermal patch: a new treatment option for the prevention of postmenopausal osteoporosis. Womens Health (Lond). 2015 Nov; 11(6):815-24.
-
Schultz TC, Valenzano JP, Verzella JL, Umland EM. Odanacatib: an emerging novel treatment alternative for postmenopausal osteoporosis. Womens Health (Lond). 2015 Nov; 11(6):805-14.
-
Jackson RD, Mysiw WJ. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative. Semin Reprod Med. 2014 Nov; 32(6):454-62.
-
Abraham L, Pinkerton JV, Messig M, Ryan KA, Komm BS, Mirkin S. Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene. Maturitas. 2014 Jul; 78(3):212-8.